Agencies working with Russia to set biosimilar standards

05/20/2013 | In-PharmaTechnologist.com

The World Health Organization, national regulatory agencies and international pharmaceutical associations met in Russia to set standards for the manufacture of biologic and biosimiliar products in that country. A key focus is establishing definitions and regulations for biosimilars, which are not yet recognized as distinct products under Russian law.

View Full Article in:

In-PharmaTechnologist.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA